Abstract:Abstract Background: Triple-negative breast cancer (TNBC) is a relatively rare subtype of breast cancer, and is prone to lymph node metastasis at early stage. However, there is a lack of prognosis prediction models. The purpose of this study is to develop and validate an effective nomogram for predicting the probability of lymph node metastasis in early-stage TNBC.Methods: We selected 26,775 eligible patients who were diagnosed with early-stage TNBC between 2010 and 2015 from the Surveillance, Epidemiology, and End Results database. All the patients were randomly divided into a training cohort and a validation cohort at a 7:3 ratio. The 266 patients in the validation cohort comprised from the Affiliated Jurong Hospital of Jiangsu University for medical records from January 2011 to August 2020 to identify patients with histologically confirmed early-stage TNBC. The predictive accuracy and identification capability of the nomogram of the clinical prediction model were determined using the concordance index (C-index), receiver operating characteristic curves (ROC), and calibration curves.Results: In all, 27,041 patients were included, with 18,929 patients in the training cohort and 8,112 patients in the validation cohort. Multivariate analysis of the training cohort showed the independent risk factors for lymph node metastasis were age, race, primary site, histological type, grade and tumor size, which were all included in the nomogram. In the training cohort, the nomogram presented robust discrimination, with a C-index of 0.712, which was similar to the C-index of 0.710 in the validation cohort. Consistently, the area under the ROC curve was 0.712 in the training cohort and 0.710 in the validation cohort, which both showed good predictive value for lymph node metastasis risk. The calibration curve showed a better agreement between the nomogram-predicted probability and the actual probability of lymph node metastasis risk.Conclusions: The prognostic nomogram for early-stage TNBC patients constructed here shows good application prospect and can assist clinicians in predicting lymph lode metastasis in early-stage TNBC.

Prediction of lymph node metastasis in early-stage triple-negative breast cancer based on a nomogram of clinicopathological parameters